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1090-218 Randomized Comparison of Anatomical Versus Voltage-
Guided Ablation of the Cavotricuspid Isthmus for Atrial 
Flutter
Burr W. Hall, Srikar Veerareddy, Peter Cheung, Kamala Tamirisa, Jihn Han, Kristina 
Lemola, Aman Chugh, Frank Pelosi, Jr., Fred Morady, Hakan Oral, University of 
Michigan, Ann Arbor, MI
Background: It is not clear whether local atrial electrogram amplitude influences the
achievement of complete cavotricuspid isthmus (CTI) block during radiofrequency abla-
tion for atrial flutter. The purpose of this study was to prospectively compare the technical
aspects and efficacy of CTI ablation using a strictly anatomic approach and using an
approach guided by a bipolar voltage map to avoid high voltage zones in the CTI.
Methods: Thirty-two patients with atrial flutter were randomized to CTI ablation with an
anatomical approach (Group I, 16 patients) or guided by a bipolar voltage map (Group II,
16 patients).A 3-D electroanatomical mapping system and an 8-mm-tip ablation catheter
(temperature target 55°, power 70W) were used in all patients. With the anatomical
approach, a line was created at a 6 o'clock position (LAO 45) in the CTI isthmus without
detailed reconstruction of the CTI geometry. During voltage-guided ablation, a high-den-
sity bipolar voltage map of the CTI was created, then contiguous applications of radiofre-
quency energy were delivered at CTI sites with the lowest bipolar voltage.
Results: Complete CTI conduction block was achieved in 100% of patients in each
group. The mean of the maximum voltages along the line were 3.3 ± 1.7 mV in Group I,
compared to 1.4 ± 0.6 mV in Group II (p<0.001). Creating a high-density voltage map
was associated with a 21 ± 11 minute increase in the total procedure time (p=0.2). During
a mean follow-up of 59 ± 44 days, there was no recurrence of atrial flutter in either group.
There were no complications in either group.
Conclusions: When CTI ablation for atrial flutter is performed with an 8-mm-tip catheter,
complete block can be achieved in all patients regardless of local voltage. Ablation of
high voltage zones is not associated with a higher incidence of recurrence. Therefore
anatomical ablation without detailed mapping may be the preferred initial approach for
CTI ablation.
1090-219 Cryoablation of Atrial Flutter: Results of a Multicenter 
Clinical Study
Robert H. Hoyt, Christopher Fellows, Roy John, Larry Chinitz, David T. Martin, Iowa 
Heart Center, Des Moines, IA
Background: Inadequate tissue contact, catheter tip instability, and pain stimulus during
radiofrequency (RF) ablation may pose difficulties when creating the linear lesion needed
for cure of typical cavo-tricuspid isthmus-dependent atrial flutter (AFL). We evaluated the
acute efficacy of cryoablation (cryo) for the treatment of isthmus-dependent AFL. Meth-
ods:30 patients with clinical AFL (23 males, mean age 66+/-9 yrs) underwent electro-
physiology study with multipolar catheters positioned in the right atrium (RA) and
coronary sinus. AFL was induced and entrained from the isthmus. Cryoablation was per-
formed with a novel 10 Fr bipolar steerable cryo-catheter and console (CryoCor, Inc.).
Contiguous 4 minute cryo applications using a freeze-thaw cycle were delivered across
the isthmus from the tricuspid valve annulus to the inferior vena cava-RA junction.
Results: A mean of 16+/-6 applications were delivered to the isthmus. Average cooling of
the catheter tip was to -80+/-4 degrees C, which is substantially colder than the tip tem-
perature attainable with other first-generation cryo-catheters. The catheter tip was adher-
ent and remained stable during cryo. Acute endpoints of non-inducibility and bi-
directional block were achieved in 28/30 patients (93%). The mean procedure time was
186+/-55 min, including at least 30 min observation post ablation, with fluoroscopy time
of 43+/-22 min. Patients reported no discomfort during application of cryo. There were no
procedure related adverse events. Conclusion: Clinical results from this study demon-
strate that when lower temperatures are achieved, trans-catheter cryoablation is highly
effective in the treatment of isthmus-dependent AFL. Catheter stability and patient com-
fort with cryo appears superior to that observed with RF ablation, whereas efficacy is
comparable.
1090-220 Atrial Tachycardia Originating From the Pulmonary 
Veins: Is Single Vein Isolation Adequate?
John D. Burkhardt, Yaariv Khaykin, George Joseph, Mandeep Bhargava, Jennifer 
Cummings, Atul Verma, Patrick Tchou, Cleveland Clinic Foundation, Cleveland, OH
Background: Atrial tachycardia may arise from the pulmonary veins and presents with
frequent paroxysms of tachycardia that are difficult to suppress with antiarrhythmic ther-
apy. Premature atrial contractions from the pulmonary veins are known to initiate atrial
fibrillation. In the age of pulmonary vein isolation for the treatment of atrial fibrillation, is
single vein isolation for atrial tachycardia curative or will atrial fibrillation arise afterward?
Objective: To evaluate the effectiveness of single pulmonary vein isolation for atrial tachy-
cardias arising from that vein and identify the long-term arrhythmia risk in those patients.
Methods: Thirteen patients underwent single pulmonary vein isolation or focal ablation
for the treatment of atrial tachycardia mapped to that vein between April of 1997 and April
of 2003. The patients were followed for a mean of 21.1 months (SEM +/- 6.7). Results:
After successful isolation or focal ablation (2 patients required more than one procedure),
none of the thirteen patients experienced further atrial tachycardia during follow up. Two
patients who had atrial fibrillation prior to the procedure continued to have atrial fibrilla-
tion afterward, but none of the patients without atrial fibrillation prior to the procedure
experienced this arrhythmia following ablation. Conclusion: Atrial tachycardias arising
from the pulmonary veins in patients without atrial fibrillation can be successfully treated
with single vein isolation without recurrence of this arrhythmia or subsequent develop-
ment of atrial fibrillation.
1090-221 Radiation Skin Exposure, Effective Organ Doses, and 
Estimated Cancer Risk for Pulmonary Vein and 
Cavotricuspid Isthmus Ablation Using a Low Frame 
Pulsed Fluoroscopy System
Lars M. Lickfett, Mahadevappa Mahesh, Chandrasekhar Vasamreddy, David Bradley, 
Vinod Jayam, Zayd Eldadah, Timm Dickfeld, Berndt Lüderitz, Ronald Berger, Hugh 
Calkins, University of Bonn, Bonn, Germany, Johns Hopkins University, Baltimore, MD
Background: Catheter ablation of the pulmonary veins (PV) represents a new treatment
option for atrial fibrillation (AF). The procedure is complex and requires prolonged fluo-
roscopy exposure. Pulsed fluoroscopy with very low frame rate (7.5 fps) can reduce radi-
ation exposure by greater than 50%. The purpose of this study was to measure radiation
exposure during PV ablation procedures using a state of the art, pulsed fluoroscopy sys-
tem and to compare it with ablation of the cavotricuspid isthmus.
Methods: 15 patients (pt) referred for PV isolation and 5 pt referred for cavotricuspid isth-
mus ablation for atrial flutter (AFL) were studied. A biplane pulsed (7.5/sec) fluoroscopy
system (Siemens Bicor HS) was used. Pt’s skin exposure was measured by 60 thermo-
luminiscent dosimeters positioned on the pt’s back, corresponding to the location of the
fluoroscopy tubes.
Results: Mean fluoroscopy time for AF was 68±21 min in RAO and 62±17 min in LAO
projection. Mean fluoroscopy time for AFL was 18±5 min in RAO and 12±7 min in LAO
projection. Mean peak skin dose for AF was 1.0±0.5 Gy in RAO and 1.5±0.4 Gy in LAO
projection. Mean peak skin dose for AFL was 0.4±0.2 Gy in RAO and 0.5±0.5 Gy in LAO
projection. For AF pts the effective organ dose was 27.3 mSv for males and 18.7 mSv for
females, resulting in an excess risk of fatal malignancy of 2099 per 1 million pts in males
and 1518 per 1 million pts in females. For AFL pts, the effective organ dose was 3.79
mSv, resulting in an excess risk of fatal malignancy of 292 per 1 million pts.
Conclusion: Even though catheter ablation of AF using a PV approach is associated
with prolonged fluoroscopy duration, the skin exposure to pts was below the threshold for
skin injury (<2Gy) for low frame rate pulsed fluoroscopy. The excess risk of fatal malig-
nancy was similar to what has been reported in the past for catheter ablation of regular
supraventricular tachycardias using conventional fluoroscopy systems.
1090-222 A Randomized Study of Prophylactic Catheter Ablation 
in High-Risk Children With Asymptomatic Wolff-
Parkinson-White Syndrome
Carlo Pappone, Vincenzo Santinelli, Francesco Manguso, Gabriele Vicedomini, 
Salvatore Rosanio, Simone Gulletta, Patrizio Mazzone, Giuseppe Augello, Vita-Salute 
San Raffaele University Hospital, Milan, Italy
Background – Adults with asymptomatic ventricular preexcitation that prophylactic
radiofrequency catheter ablation of accessory pathways is of benefit in preventing life-
threatening arrhythmic events and ventricular fibrillation.
Objective – A randomized comparison of prophylactic radiofrequency catheter ablation
of accessory pathways versus no ablation in high-risk children.
Methods – The subjects were asymptomatic high-risk children of ages 5 to 17 years with
Wolff-Parkinson-White syndrome. An increased risk was defined as inducibility of sus-
tained atrioventricular reciprocating tachycardia and/or sustained atrial fibrillation at elec-
trophysiologic testing. The main endpoint was the occurrence of arrhythmic events over a
5-year follow-up period.
Results – Of the 172 enrolled children, 47 patients (27%) completed the study (20
received prophylactic ablation). The baseline clinical and electrophysiologic characteris-
tics of the two randomized groups were similar. The median hospital stay was 2 days in
each group. There was a higher rate of symptomatic arrhythmic events in the control
group than in the ablation group (7 events vs. 0 events, P=0.002). The event-free rates at
5 years among patients in the ablation and control groups were 100% and 74% (Figure),
respectively.
Conclusions – We found a significant and durable benefit of prophylactic ablation of
accessory pathways over no treatment in pediatric high-risk subjects with asymptomatic
Wolff-Parkinson-White syndrome. 
